Turn Therapeutics Inc. 8-K

What Happened
On May 19, 2026, Turn Therapeutics Inc. announced and furnished a press release and filed a Current Report on Form 8‑K under Item 7.01 (Regulation FD Disclosure). The press release is included as Exhibit 99.1 to the filing. The 8‑K does not report earnings, executive changes, or other material agreements.

Key Details

• Filing date: May 19, 2026 (Form 8‑K, Item 7.01 Regulation FD Disclosure).
• Press release furnished as Exhibit 99.1 to the 8‑K.
• No additional items reported (the filing does not include financial statements, executive appointments, or material contracts).
• The filing includes the standard interactive data cover page (Inline XBRL) as Exhibit 104.

Why It Matters
This filing formally documents the company’s public release of information under Regulation FD so all investors have access to the same disclosure. Retail investors should read the press release (Exhibit 99.1) to determine whether it contains material news—such as clinical updates, commercial milestones, or strategic developments—that could affect the company. The 8‑K itself contains no other corporate or financial disclosures.